Concepedia

Jonathan W. Day

JW

Statistics

Publications

9

Citations

999

H-Index

9

Active since

2009

Affiliations

Indiana University Bloomington(Current)

Eli Lilly (United States)

Acadia Pharmaceuticals (United States)

University of Cincinnati

Scripps Research Institute

Jonathan W. Day is an author at Indiana University Bloomington specializing in life sciences, signal transduction, and ligand binding.

Publications per year

2009–2025

9

Publications

9

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

Jonathan W. Day, Nickki Ottaway, James T Patterson et al. · Nature Chemical Biology · 2009 · 634 citations · Full text

, , +14

Optimization of co‐agonism at GLP‐1 and glucagon receptors to safely maximize weight reduction in DIO‐rodents

Jonathan W. Day, Vasily M. Gelfanov, David L. Smiley et al. · Biopolymers · 2012 · 134 citations

, , +17

Preclinical Characterization of LY3209590, a Novel Weekly Basal Insulin Fc-Fusion Protein

Julie S. Moyers, Ryan J. Hansen, Jonathan W. Day et al. · Journal of Pharmacology and Experimental Therapeutics · 2022 · 54 citations · Full text

, , +8

An anti-ANGPTL3/8 antibody decreases circulating triglycerides by binding to a LPL-inhibitory leucine zipper-like motif

Deepa Balasubramaniam, Oliver C. Schroeder, Anna M. Russell et al. · Journal of Lipid Research · 2022 · 49 citations · Full text

, , +17

Identification of metal ion binding peptides containing unnatural amino acids by phage display

Jonathan W. Day, Chan Hyuk Kim, Vaughn V. Smider et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 43 citations

, , +16

1–5 of 9